Formic Acid

Formic Acid

SCHEMBL30349992

COc1ccc(-c2cnc3c(Nc4cc(C)c(C(N)=O)c(F)c4)nccn23)c(F)c1F.O=CO

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ZAP70 P43403 15/20 0.39
▸ KARS1 Q15046 10/20 0.39
▸ SYK P43405 10/20 0.38
▸ MAPKAPK5 Q8IW41 1/20 0.37
▸ CDC7 O00311 1/20 0.36
▸ PLK4 O00444 1/20 0.36
▸ DYRK3 O43781 1/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ PRKD3 O94806 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CSF1R P07333 1/20 0.36
▸ MET P08581 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ PHKG2 P15735 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ CLK2 P49760 1/20 0.36
▸ GSK3A P49840 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22123524 0.90 TTK (0.37) ZAP70KARS1SYKMAPKAPK5
Hydrochloric Acid SCHEMBL30385412 0.90 TTK (0.37) ZAP70KARS1SYKMAPKAPK5
Hydrochloric Acid SCHEMBL22123495 0.90 TTK (0.37) ZAP70KARS1SYKMAPKAPK5
Formic Acid SCHEMBL30171996 0.88 ZAP70 (0.39) ZAP70KARS1SYK
SCHEMBL30171910 0.87 BRD4 (0.36) ZAP70KARS1SYKMAPKAPK5
Formic Acid SCHEMBL22123789 0.87 PDE10A (0.34) ZAP70KARS1SYK
SCHEMBL22123380 0.86 ZAP70 (0.39) ZAP70KARS1SYK
SCHEMBL30171548 0.86 ZAP70 (0.39) ZAP70KARS1SYK
Formic Acid SCHEMBL30171987 0.86 ALK (0.38) ZAP70KARS1SYKMAP4K4MAP4K2
SCHEMBL22122949 0.85 ZAP70 (0.40) ZAP70KARS1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230017532-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230017532-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES MRPL21, O60361, MYD88 ZAP70 716/4885KARS1 610/4885SYK 939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback